Zhejiang AngLiKang Pharmaceutical CO.,LTD.

SZSE:002940.SZ

17.9 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017201620152014
Revenue 1,625.8671,568.4371,380.3781,289.6471,396.1941,255.048873.154671.581773.794681.508
Cost of Revenue 900.509670.548487.759317.373375.321378.345409.552454.885594.83523.764
Gross Profit 725.358897.889892.618972.2741,020.873876.703463.603216.696178.964157.744
Gross Profit Ratio 0.4460.5720.6470.7540.7310.6990.5310.3230.2310.231
Reseach & Development Expenses 143.369112.62252.55343.87737.34746.20940.96546.83640.62636.629
General & Administrative Expenses 57.96417.29536.56433.3545.54331.59128.58710.85112.11267.498
Selling & Marketing Expenses 293.019559.078609.81690.89765.204646.752231.57327.9321.95423.387
SG&A 350.983576.373646.374724.24810.748678.343260.15938.78134.06690.885
Other Expenses -4.48263.83332.0370.21422.0346.074-0.1795.847.0946.907
Operating Expenses 509.021752.828730.964768.331870.129756.447328.177110.77898.31194.39
Operating Income 211.681148.558174.171211.681155.103131.239123.71689.32661.03249.721
Operating Income Ratio 0.130.0950.1260.1640.1110.1050.1420.1330.0790.073
Total Other Income Expenses Net -4.482-1.613-1.524-0.936-1.41317.057-11.888-10.752-12.527-13.185
Income Before Tax 207.2146.945172.647210.745153.69137.313123.53795.16668.12650.17
Income Before Tax Ratio 0.1270.0940.1250.1630.110.1090.1410.1420.0880.074
Income Tax Expense 24.13514.95731.32529.44427.23215.64418.10414.23410.0288.664
Net Income 138.372127.296119.844163.719112.27108.697101.08582.18864.02750.128
Net Income Ratio 0.0850.0810.0870.1270.080.0870.1160.1220.0830.074
EPS 0.690.640.610.860.590.730.710.580.450.35
EPS Diluted 0.690.640.610.860.590.730.710.580.450.35
EBITDA 312.758219.992222.278259.392193.683169.14167.468146.054128.282106.163
EBITDA Ratio 0.1920.140.1610.2010.1390.1350.1920.2170.1660.156